Purpose: Cerebral cavernous malformations (CCMs) are frequently associated with intractable epilepsy. Whereas surgery indication in single CCMs is clear, data regarding the efficacy of epilepsy surgery in patients with multiple CCMs are scarce. We sought to clarify diagnostic requirements and postoperative outcome in patients with multiple CCMs and refractory epilepsy. Methods: Retrospective analysis of clinical records of hospitalized patients who underwent comprehensive diagnostic work-up including long-term video-EEG monitoring. Results: From a total of 63 consecutive patients with CCMs and medically refractory epilepsy, 11 (17%) had multiple CCMs and underwent epilepsy surgery. There were three females and eight males. Mean age at epilepsy onset was 28.3 years (S.D. 12.3), and at epilepsy surgery, 40.7 years (S.D. 10.3). On average, each patient had 3.7 (S.D. 2.2) supratentorial CCMs. In all cases we identified only one epileptogenic zone. The epileptogenicity was higher for the CCMs located within the temporal lobe. At 2 years follow-up, the outcome according to the Engel classification was Ia (seizure-free) in nine patients (81.8%) and IIb (rare seizures) and IVc (worsening) in two patients, respectively. In one patient, a dual pathology was present and, in another case, de novo appearance of CCMs was demonstrated. Conclusions: Our results show that postoperative outcome in patients with multiple CCMs can be as good as in those with single malformations if proper presurgical identification of the epileptogenic CCMs is done. The possibility of the novo appearance of CCMs or dual pathology may occur and may affect longterm outcome negatively.
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Method
We reviewed retrospectively the files of all patients with focal epilepsy who were evaluated at our epilepsy center during a 8-year period (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) . A total of 750 files were screened for cavernous malformations.
On admission, all patients were examined routinely, including brain MRI on a Siemens Magnetom Vision (1.5 T) with T1, T2, FLAIR and FLASH gradient echo sequences. Additionally, three patients had PET and SPECT. All patients underwent presurgical evaluation with long-term video-EEG monitoring, as well as neuropsychological, and psychiatric testing.
During monitoring, standard antiepileptic drugs (AEDs) were partially or totally discontinued in all cases. Long-term video-EEG monitoring was performed using surface electrodes placed according to the international 10-20 system, with selective use of additional Sp1/Sp2 sphenoidal electrodes. Only one patient underwent extraoperative invasive electrocorticography (ECoG).
Comprehensive electrophysiological data obtained from continuous video-EEG/ECoG recordings were analyzed. Ictal EEG activity was evaluated for lateralization, location of seizure onset and propagation in order to correlate this information with: (1) MRI localization of malformations, (2) the presumed epileptogenicity of different lesions, and (3) with semiological phenomena observed during digital video-monitoring.
Results

Clinical data
From a total of 63 consecutive patients evaluated in our center with CCMs and medically refractory epilepsy, eleven patients (17%) with multiple CCMs were considered to be surgical candidates and underwent epilepsy surgery. There were three females and eight males, with a mean age of 45.4 years (range 27-57 years, S.D. 9.2 years).
Mean age at seizure onset was 28.3 years (S.D. 12.3 years). Mean age at epilepsy surgery was 40.7 years (S.D. 10.3 years) ( Table 1 ).
Clinical manifestations
In all patients the first clinical manifestation was epilepsy. One patient suffered also from migrainous headaches. Two patients showed signs of recent bleeding on MR-imaging at diagnosis of epilepsy. Neurological examination was normal in all patients.
Seizure types and frequency
The mean frequency of seizures was 14 per month. All patients had partial seizures (nine patients complex partial and eight simple partial seizures), eight additionally suffered from secondary generalized seizures.
Family history
A positive family history for multiple CCMs was present at first evaluation in six patients (54%); in four of them (36%), CCMs were associated with epilepsy.
Topographical distribution of supratentorial CCMs
On average, each patient had 3.7 (S.D. 2.2) supratentorial CCMs at presurgical evaluation (Fig. 1) . In one patient (patient 3) the formation of new CCMs after surgery was demonstrated by repeated MRI examinations.
From a total of 41 supratentorial CCMs, 16 were frontal (39%), 11 temporal (27%), 9 parietal (22%), 3 occipital (7%) and 2 insular (5%) (Fig. 2) . Five patients (45%) had also additional infratentorial CCMs.
Relationship between localization, size and epileptogenicity
According to presurgical evaluation, we found a total of 14 epileptogenic CCMs in our 11 patients. With respect to epilepto- genic CCMs, eight were localized in the temporal lobe (58%), three in the parietal lobe (21%), two in the frontal lobe (14%) and one in the insula (7%). In three cases, two adjacent CCMs were found to be epileptogenic and resected in the same procedure (cases 6, 8 and 9). Two of them were located in the temporal lobe and one in the frontal lobe. Considering the relationship between epileptogenicity and localization, we found that 2 of 16 frontal, 3 of 9 parietal and 8 of 11 temporal CCMs were epileptogenic, showing a proportion of 0.12, 0.33 and 0.72, respectively (Fig. 3) . We also measured the diameter of the largest (range 8.8-56.9 mm) and the operated cavernoma. Only in 6 out of 11 (54%) patients the largest cavernoma was considered to be epileptogenic and therefore resected.
In seven patients with TLE, we calculated the distance between the resected CCM and the hippocampus, in order to determine its significance in the therapeutic procedure. On average, the distance was 9.44 mm (range 0.2-28.8). In one patient, who underwent amygdalohippocampectomy with CCM resection, the distance between lesion and hippocampus was 0.9 mm.
Diagnostic EEG procedure
All but one patient were studied with long-term video-EEG monitoring using non-invasive recordings. Implanted electrodes were used in only one case for language localization in a patient with close spatial relationship between the cavernoma and Wernicke's area and unclear findings in both, Wada testing and f-MRI. In ten patients ictal events were registered, and in one patient only interictal activity. In all patients a detailed semiologic analysis of each seizure was performed in order to correlate seizure onset area and lesion localization.
Interictal activity concordant to the suspected epileptogenic lesion in the form of sharp-waves was found in nine patients. However, interictal spiking unrelated to the zone of seizure onset was present in four patients. Interestingly, in three cases additional CCMs were found in these areas (unrelated irritative zone). During the video-EEG monitoring in which AEDs were gradually tapered off, no complications or medically hazardous situations occurred.
Surgical procedure
In seven patients extended lesionectomy of a single cavernoma including the contiguous hemosiderin (yellow dyed) containing tissue was performed. In three other patients, extended resection of two adjacent CCMs was done (patients 6, 8 and 9), and in an additional patient with a dual pathology (patient 5) amygdalohippocampectomy was performed in addition to lesionectomy.
Patients 1 and 10 had been previously operated without extensive presurgical evaluation and without favorable seizure outcome. In patient 1, a resection of right parietal CCM was carried out. In patient 10, a resection of a left sided cavernoma located in the superior temporal gyrus was performed years before and now, a lesionectomy of a left mesial temporal cavernoma with a temporal pole resection was done.
Neuronavigation was routinely used during the surgical procedures in all patients. Remaining hemosiderin rests were found on MRI examinations 3 months after the surgery in 8 out of 11 patients.
Complications after surgery
Four patients suffered from expected visual field defects directly resulting from the surgical procedure. One patient (patient 4), in whom amygdalohippocampectomy was combined with extended lesionectomy, had a residual minor hemiparesis and dysphasia, due to an infarction near the internal capsula.
Histopathology
A CCM with associated hemosiderin deposits was confirmed histopathologically in all patients.
Seizure outcome
The outcome according to the Engel classification was Ia (seizure-free) in ten patients and Ib (only auras) in one patient 6 months postoperatively. At 1-year follow-up, two initially seizurefree patients deteriorated and were actually IIb (rare seizures) and IVc (worsening), respectively. At 2 years follow-up, no further worsening in the seizure outcome was observed ( Table 2 ). In contrast, one patient who initially had only auras became seizurefree. In two out of three patients without complete seizure control, an incomplete hemosiderin ring resection was observed on postoperative MRI. Nevertheless, seven other patients who were seizure-free had some hemosiderin rests on postoperative MRI.
Discussion
It has been shown that approximately 4% of pharmacoresistant focal epilepsies are caused by CCMs. 17, 18 As expected, focal seizures are the most common clinical presentation form in CCMs, including simple, complex and generalized seizures. 19, 20 CCMs are twice as likely associated with seizures when compared with other lesions, such as AVMs and tumors with similar volume distributions and identical locations. 21 The pathophysiological basis of seizures in CCMs seems to refer to micro-hemorrhages with the exposure of the surrounding brain to blood breakdown products, particularly iron and the subsequent gliotic reaction. 22, 23 In followup studies modifications in size and signal characteristics of the lesions have been observed. 24 Moreover the development of secondary epileptogenic foci should be considered in patients with dual pathology. 25 Longtime studies of patients with symptomatic epilepsy and CCMs are lacking. The optimal management is still a matter of debate. 26 In particular, the presence of multiple CCMs demands accurate presurgical diagnostic work-up to precisely localize seizure origin. In our series, mean age of patients at first seizure was 28.3 years. Seizure control with AEDs was disappointing, and few years after onset of epilepsy it was evident that the seizures were nor controlled with AEDs. However, the mean time until epilepsy surgery was considerably long (12.3 years). This fact strongly indicates that epilepsy surgery should be considered early after diagnosis of a pharmacoresistant epilepsy. Furthermore, the mean seizure frequency was relatively high (14 per month), but in no case status epilepticus was noted.
Six of our patients (54%) had a positive family history for multiple CCMs, although we cannot rule out the existence of silent lesions in the other families. Considering that the possibility to find a positive hereditary trait is high, the option to perform a MRI in first-degree family members should be discussed, in particular if there is a history of headache, seizures or stroke and related symptoms.
We used the 10-20 BBG-system with facultatively additional sphenoidal electrodes to identify the epileptogenic area. Only in one bilateral-handed patient an invasive procedure was required due to unclear lateralization of language.
Through video-EEG we could localize the zone of seizure onset (SO) adequately in nine patients. In none of them we found EEG data suggesting additional seizure foci, although in four patients we had evidence of interictal epileptic activity unrelated to SO. Of the remaining two patients ictal EEG analysis was not possible due to artefacts in one case (patient 4), and absent seizures in the second patient (patient 6) despite complete AED withdrawal. In these cases, a careful analysis of seizure semiology and interictal spiking, respectively in correlation with cavernoma localization was sufficient to determinate seizure origin.
Seizure outcome 1 year after lesionectomy in our series showed that nine patients (81%) remained free of seizures or had only auras (Engel I). At 2 years follow-up, no deterioration was noted. Unexpected surgical complications were observed in only one patient (patient 5).
The serial MRI controls revealed postoperative hemosiderin rest in 8 out of 11 patients. It seems to be remarkable that the two patients with persistent seizures have hemosiderin rests. Most authors share the opinion that extended lesionectomy results in better seizure outcome. [27] [28] [29] However, other studies did not find evidence supporting this hypothesis.
6,30,31
We did not find any positive correlation between number of CCMs, seizure frequency, and postoperative outcome. Postoperative seizure outcome in our series indicates that only the resected CCMs were responsible for the seizure generation. The favorable outcome of two patients who had been unsuccessfully operated without correct diagnosis after exact determination of the epileptogenic CCM speaks in favor of thorough preoperative work-up. In both cases the diagnostic procedure demonstrated that the operated cavernoma had not been the epileptogenic lesion, corresponding to the poor seizure outcome. Thus, when more than one lesion is located in the epileptogenic zone, resection of all malformations may offer advantages if there is no additional risk of neuropsychological or motor deficits. Furthermore, in cases in which the CCMs are very close to each other a neurophysiological differentiation of the individual epileptogenicity of each cavernoma through superficial EEG is usually not possible.
De novo appearance of CCMs has been demonstrated previously. 32, 33 At least in one case (patient 2), we observed the novo appearance of CCMs 3 years after the epilepsy surgery. The appearance of new lesions, possibly higher in patients with a hereditary trait, could be a factor negatively influencing seizure control. This possibility imposes, in case of seizure recurrence, the necessity of serial MRI examinations and eventually repeated video-EEG monitoring.
On the other hand, dual pathology, i.e. the coexistence of temporo-mesial sclerosis and, in this case, one or more temporal CCMs were observed in another patient. In this situation, it can be particularly difficult to identify the lesion responsible for seizure generation. From an epileptological point of view, seizure semiology and EEG characteristics of seizure onset can provide information in order to differentiate a mesial or lateral seizure origin. Nonetheless, thorough distinction may not be possible if there is rapid propagation of epileptic activity. In this situation, invasive diagnostic work-up with intraoperative/perioperative ECoG and implementation of more sensitive MRI-techniques, can provide the necessary information in order to clarify the epileptogenic area. Consequently, in temporal lobe CCMs, due to potentially relevant memory deficits, an additional hippocampectomy should only be performed if there is clear evidence of its involvement in seizure generation.
The distribution of supratentorial CCMs corresponded roughly the volume proportion of each cerebral lobe. However the epileptogenicity, i.e. the capability to generate seizures, was higher in the temporal lobe. Although temporal CCMs represented only 27% of the total supratentorial CCMs, they accounted for 58% of epileptogenic CCMs. It has been suggested that temporal lobe CCMs are more likely to be associated with intractability of seizures. 30 The opposite holds for the frontal lobe: whereas 39% of CCMs were found, only 14% of there were epileptogenic. However, this is not generally accepted. 1 Measuring the maximal diameter of the CCMs, we could not find any clear relationship between size of the CCM and its epileptogenicity. Only in 54% of patients, the largest cavernoma was involved in the generation of seizures. The distance between the vascular malformation and the hippocampal formation did not influence the surgical procedure, although the average distance was only 9.4 mm (range 0.2-28.8).
Conclusions
A retrospective study of patients with medically refractory epilepsy and multiple supratentorial CCMs who underwent epilepsy surgery at our epilepsy center is presented. We conclude from our limited experience that the postoperative outcome of patients with multiple CCMs seems to be as favorable as of patients with single lesions. Therefore, surgical treatment in multiple CCMs should be considered early after recognition of seizure intractability. In most cases, invasive diagnostic procedures are not necessary. Nonetheless, the possibility of a de novo appearance of CCMs and, as a result, the development of new epileptogenic foci should be recognized.
